Results 41 to 50 of about 5,472 (197)

Year in review in Intensive Care Medicine 2012. II: Pneumonia and infection, sepsis, coagulation, hemodynamics, cardiovascular and microcirculation, critical care organization, imaging, ethics and legal issues. [PDF]

open access: yes, 2013
Journal ArticleSCOPUS: re.jSCOPUS: re.jinfo:eu-repo/semantics ...
Antonelli, Massimo   +18 more
core   +2 more sources

Is there any role for terlipressin in the extremely low birth weight infant with refractory septic shock?

open access: yesJournal of Pediatric and Neonatal Individualized Medicine, 2012
Terlipressin, a synthetic long-acting analogue of vasopressin, has been investigated as a second line vasopressor in adults and children with refractory septic shock, i.e.
Francesca Bissolo   +5 more
doaj   +1 more source

Iatrogenic bleeding during flexible bronchoscopy: risk factors, prophylactic measures and management. [PDF]

open access: yes, 2017
Significant iatrogenic bleeding during flexible bronchoscopy is fortunately rare and usually self-limiting. Life-threatening bleeding, however, can occur, especially after conventional or cryoprobe-assisted transbronchial biopsy.
Breuer   +27 more
core   +3 more sources

Continuous terlipressin infusion is associated with improved diet intake and muscle strength in patients awaiting liver transplant

open access: yesJHEP Reports, 2019
Background & Aims: Portal hypertension contributes to the pathogenesis of malnutrition and sarcopenia in cirrhosis via multiple mechanisms. Terlipressin is a vasopressin analogue that we administer via continuous outpatient infusion, as a bridge to ...
Brooke Chapman   +8 more
doaj   +1 more source

Cardiovascular drug therapy for human newborn: review of pharmacodynamic data [PDF]

open access: yes, 2017
BACKGROUND: Circulatory failure in preterm and term newborn infants is commonly treated with inotropes or vasoactive medications. In this structured literature review, the available data on pharmacodynamic effects of the inotropes adrenaline ...
Bravo, MC   +5 more
core   +1 more source

Effects of terlipressin infusion during hepatobiliary surgery on systemic and splanchnic haemodynamics, renal function and blood loss: a double-blind, randomized clinical trial

open access: yesBMC Anesthesiology, 2019
Background Terlipressin, in general, is a vasopressor which acts via V1 receptors. Its infusion elevates mean blood pressure and can reduce bleeding which has a splanchnic origin.
Magdy Mohammed Mahdy   +12 more
doaj   +1 more source

Severe Bradycardia Associated with the Use of Terlipressin: A Case Report

open access: yesCase Reports in Gastroenterology
Introduction: Although terlipressin is known to cause bradycardia, this adverse effect is usually described in association with hypertension and is considered a benign compensatory response mediated by arterial baroreceptors.
Alex Yartsev, Jessica T. Nguyen
doaj   +1 more source

Terlipressin combined with conservative fluid management attenuates hemorrhagic shock-induced acute kidney injury in rats

open access: yesScientific Reports, 2022
Hemorrhagic shock (HS), a major cause of trauma-related mortality, is mainly treated by crystalloid fluid administration, typically with lactated Ringer’s (LR).
Leticia Urbano Cardoso Castro   +10 more
doaj   +1 more source

Aszites, Pfortaderthrombose und hepatische Enzephalopathie bei Leberzirrhose: Aktuelle Therapieempfehlungen [PDF]

open access: yes, 2012
Treatment of Ascites, Portal Vein Thrombosis and Hepatic Encephalopathy in Patients with Cirrhosis of the Liver Background: Ascites, portal vein thrombosis and hepatic encephalopathy are important complications of cirrhosis of the liver.
Abecasis R   +46 more
core   +1 more source

Terlipressin-Related Acute Myocardial Infarction: A Case Report and Literature Review

open access: yesKaohsiung Journal of Medical Sciences, 2004
Acute ST-segment elevation myocardial infarction after the administration of terlipressin in patients with hemorrhagic esophageal varices is a rare but life-threatening complication.
Min-Yi Lee   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy